ONTOLOGY REPORT - ANNOTATIONS
| Term: | fructose |
|
| Accession: | CHEBI:28757
|
browse the term
|
| Synonyms: | exact_synonym: | arabino-hex-2-ulose |
| | related_synonym: | C6H12O6; Fru; Fruchtzucker; Fruktose; arabino-Hexulose |
| | alt_id: | CHEBI:24104; CHEBI:24110; CHEBI:5172 |
| | xref_casrn: | 30237-26-4 |
| | xref: | ChemIDplus:30237-26-4 "CAS Registry Number"; DrugBank:DB04173 "DrugBank"; KEGG COMPOUND:C01496 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D005632 |
|
|
fructose
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
decreases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
EXP |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
decreases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases secretion |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
increases expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
increases expression |
EXP |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
multiple interactions |
EXP |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
increases expression |
ISO |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
increases expression |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
increases expression |
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
increases expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
multiple interactions |
EXP |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
increases expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
increases expression |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
increases expression |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
EXP |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases response to substance |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
increases expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
increases expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases uptake |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
increases phosphorylation |
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
multiple interactions |
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
increases phosphorylation |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
multiple interactions |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
increases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
decreases expression |
EXP |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
increases activity |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
increases expression |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
multiple interactions |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
increases expression |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases expression |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases activity |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases activity |
EXP |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
increases expression |
EXP |
4 |
149,622,566 |
149,628,111 |
RGD:6480464 |
CTD |
| G |
Gnat3 |
guanine nucleotide binding protein, alpha transducing 3 |
|
affects response to substance |
ISO |
4 |
12,785,190 |
12,834,880 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
multiple interactions |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
increases expression |
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
EXP |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
increases expression |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases secretion |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases response to substance |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
EXP |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
multiple interactions |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
increases expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
decreases expression |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
decreases expression |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
multiple interactions |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
multiple interactions |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
increases expression |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
increases expression |
EXP |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
multiple interactions |
EXP |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
increases expression |
EXP |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Klk1 |
kallikrein 1 |
|
multiple interactions |
EXP |
1 |
94,624,828 |
94,628,822 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases expression |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases secretion |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases secretion |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Mlx |
MLX, MAX dimerization protein |
|
increases expression |
EXP |
10 |
90,104,233 |
90,108,952 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mt-atp6 |
mitochondrially encoded ATP synthase 6 |
|
increases expression |
EXP |
MT |
7,919 |
8,599 |
RGD:6480464 |
CTD |
| G |
Mt1-ps2 |
metallothionein 1, pseudogene 2 |
|
multiple interactions |
EXP |
2 |
11,261,631 |
11,262,790 |
RGD:6480464 |
CTD |
| G |
Mt1-ps2 |
metallothionein 1, pseudogene 2 |
|
increases expression |
EXP |
2 |
11,261,631 |
11,262,790 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh6 |
myosin, heavy chain 6, cardiac muscle, alpha |
|
increases expression |
ISO |
15 |
33,044,506 |
33,068,098 |
RGD:6480464 |
CTD |
| G |
Myh6 |
myosin, heavy chain 6, cardiac muscle, alpha |
|
multiple interactions |
ISO |
15 |
33,044,506 |
33,068,098 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngfr |
nerve growth factor receptor |
|
decreases expression |
EXP |
10 |
84,262,804 |
84,281,006 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases activity |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
multiple interactions |
ISO |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
multiple interactions |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Paip2 |
poly(A) binding protein interacting protein 2 |
|
multiple interactions |
ISO |
18 |
28,223,680 |
28,240,856 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases activity |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
increases expression |
EXP |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
affects degradation |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
affects expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
decreases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
multiple interactions |
EXP |
9 |
85,291,203 |
85,295,242 |
RGD:6480464 |
CTD |
| G |
Pyy |
peptide YY (mapped) |
|
affects expression |
EXP |
10 |
91,174,365 |
91,175,488 |
RGD:6480464 |
CTD |
| G |
Rbmx |
RNA binding motif protein, X-linked |
|
multiple interactions |
EXP |
X |
142,112,807 |
142,119,267 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
EXP |
12 |
2,499,630 |
2,501,370 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
decreases expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
affects response to substance |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases secretion |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
multiple interactions |
ISO |
10 |
56,432,474 |
56,435,654 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
decreases expression |
ISO |
10 |
56,432,474 |
56,435,654 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
increases expression |
ISO |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
increases expression |
EXP |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
increases expression |
EXP |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
increases expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
increases expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases transport |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases transport |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
affects expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases uptake |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases uptake |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases transport |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases activity |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a7 |
solute carrier family 2 (facilitated glucose transporter), member 7 |
|
increases transport |
ISO |
5 |
167,287,943 |
167,318,833 |
RGD:6480464 |
CTD |
| G |
Slc2a7 |
solute carrier family 2 (facilitated glucose transporter), member 7 |
|
increases transport |
ISO |
5 |
167,287,943 |
167,318,833 |
RGD:6480464 |
CTD |
| G |
Slc2a9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
|
increases transport |
ISO |
14 |
77,624,411 |
77,740,695 |
RGD:6480464 |
CTD |
| G |
Slc2a9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
|
multiple interactions |
ISO |
14 |
77,624,411 |
77,740,695 |
RGD:6480464 |
CTD |
| G |
Slc31a1 |
solute carrier family 31 (copper transporters), member 1 |
|
multiple interactions |
EXP |
5 |
79,359,420 |
79,385,988 |
RGD:6480464 |
CTD |
| G |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
|
decreases expression |
EXP |
14 |
62,660,006 |
62,679,311 |
RGD:6480464 |
CTD |
| G |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
|
affects expression |
EXP |
14 |
62,660,006 |
62,679,311 |
RGD:6480464 |
CTD |
| G |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
|
multiple interactions |
EXP |
14 |
62,660,006 |
62,679,311 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
increases expression |
EXP |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
ISO |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions |
ISO |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
ISO |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
increases expression |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Soat2 |
sterol O-acyltransferase 2 |
|
decreases expression |
EXP |
7 |
140,890,902 |
140,903,999 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects binding |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
multiple interactions |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
increases glycation |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
affects response to substance |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
affects localization |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
multiple interactions |
EXP |
4 |
22,688,597 |
22,711,432 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
increases expression |
EXP |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
multiple interactions |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
affects localization |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
D-fructose 1,6-bisphosphate
|
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases degradation |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
Term paths to the root
|